Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Auer

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Acta Psychologica|April 24, 2026
Differences in online gambling expenditure between players from Germany, Spain, Netherlands, Great Britain, US and Canada: A largescale online player tracking studyMichael Auer, Mark D Griffiths
Journal of Gambling Studies|March 20, 2013
An empirical investigation of theoretical loss and gambling intensityMichael Auer, Mark D Griffiths
Journal of Gambling Studies|July 19, 2022
Using artificial intelligence algorithms to predict self-reported problem gambling with account-based player data in an online casino settingMichael Auer, Mark D Griffiths
Frontiers in Psychology|January 22, 2013
The irrelevancy of game-type in the acquisition, development, and maintenance of problem gamblingMark D Griffiths, Michael Auer
Journal of Gambling Studies|April 25, 2014
Theoretical Loss and Gambling Intensity (Revisited): A Response to Braverman et al. (2013)Michael Auer, Mark D Griffiths
Handbook of Clinical Neurology|November 8, 2017
Vascular diseases and bleedingsHarald Hegen, Michael Auer, Florian Deisenhammer
Expert Opinion on Drug Metabolism & Toxicology|October 1, 2015
Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-βHarald Hegen, Michael Auer, Florian Deisenhammer
Clinical Chemistry and Laboratory Medicine|April 16, 2014
Serum glucose adjusted cut-off values for normal cerebrospinal fluid/serum glucose ratio: implications for clinical practiceHarald Hegen, Michael Auer, Florian Deisenhammer
Drugs|September 23, 2016
Predictors of Response to Multiple Sclerosis Therapeutics in Individual PatientsHarald Hegen, Michael Auer, Florian Deisenhammer
The New England Journal of Medicine|April 28, 2017
Ocrelizumab in Primary Progressive and Relapsing Multiple SclerosisFlorian Deisenhammer, Michael Auer, Harald Hegen
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Acta Psychologica|April 24, 2026
Differences in online gambling expenditure between players from Germany, Spain, Netherlands, Great Britain, US and Canada: A largescale online player tracking studyMichael Auer, Mark D Griffiths
Journal of Gambling Studies|March 20, 2013
An empirical investigation of theoretical loss and gambling intensityMichael Auer, Mark D Griffiths
Journal of Gambling Studies|July 19, 2022
Using artificial intelligence algorithms to predict self-reported problem gambling with account-based player data in an online casino settingMichael Auer, Mark D Griffiths
Frontiers in Psychology|January 22, 2013
The irrelevancy of game-type in the acquisition, development, and maintenance of problem gamblingMark D Griffiths, Michael Auer
Journal of Gambling Studies|April 25, 2014
Theoretical Loss and Gambling Intensity (Revisited): A Response to Braverman et al. (2013)Michael Auer, Mark D Griffiths
Handbook of Clinical Neurology|November 8, 2017
Vascular diseases and bleedingsHarald Hegen, Michael Auer, Florian Deisenhammer
Expert Opinion on Drug Metabolism & Toxicology|October 1, 2015
Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-βHarald Hegen, Michael Auer, Florian Deisenhammer
Clinical Chemistry and Laboratory Medicine|April 16, 2014
Serum glucose adjusted cut-off values for normal cerebrospinal fluid/serum glucose ratio: implications for clinical practiceHarald Hegen, Michael Auer, Florian Deisenhammer
Drugs|September 23, 2016
Predictors of Response to Multiple Sclerosis Therapeutics in Individual PatientsHarald Hegen, Michael Auer, Florian Deisenhammer
The New England Journal of Medicine|April 28, 2017
Ocrelizumab in Primary Progressive and Relapsing Multiple SclerosisFlorian Deisenhammer, Michael Auer, Harald Hegen
Pageof 12